Clinical Trial Update: Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating fatty acid synthase inhibition to enhance neoadjuvant chemotherapy in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Kathy Miller | Conditions: Cancer of the Breast | Phase 2 | Status: COMPLETED | Results posted: 2020-06-19